- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Activity pressure is constructive, supporting the smart-money activity read.
AMGN34
SAO
Week ended 31 Jul 2026
Weekly Investor Report
Amgen Inc. · Healthcare · Drug Manufacturers - General
Latest close
69.89 BRL
2.4%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 7.7% above the Trend Line and sits at 74.6% of its 52-week range. The latest completed week returned 2.4%, after a 0.2% four-week move. The latest news-sentiment score is 59/100. Near-term considerations: volume confirmation is below normal.
Setup score
55
out of 100
Latest Close
69.89 BRL
31 Jul 2026
1W Return
2.4%
latest completed week
4W Return
0.2%
short-term follow-through
12W Return
21.4%
quarterly tape
Trend Breadth
48.1%
25 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- 2 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.4%
Latest completed week; four-week move 0.2%.
Indicator stack
26/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
59/100
18 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 7.7% above the Trend Line and sits at 74.6% of its 52-week range. The latest completed week returned 2.4%, after a 0.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5912-week average 0.46
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.59Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.2% over four weeks, 21.4% over 12 weeks, and 21.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year25
Trend breadth48.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.72Latest activity-pressure read.
Pressure change2900.8%Four-week change in activity pressure.
Leadership5.32Latest relative-leadership reading.
RS change-15.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment59/100
Weighted news tone is neutral across 18 relevant articles.
7 positive · 11 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-9.7%Distance below the 52-week high.
13-week volatility4.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher13 of 2613 weeks finished lower.
Best week+9.4%Week of 6 Feb.
Worst week-5.9%Week of 20 Mar.
Latest week+2.4%Week of 31 Jul.
Shape of recent returns
Strong gains4
Modest gains9
Flat weeks0
Modest losses10
Sharp losses3
Recent vol4.0%13-week weekly-return volatility.
Base vol6.6%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew4.5% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorBR Healthcare
4-week rank33 / 81
Group average-2.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD65.4%positive activity pressure
RS37.0%positive relative leadership
Four-week leaders
IndustryBR Drug Manufacturers - General
4-week rank3 / 13
Group average-3.8%
Trend breadth38.5%
Trend38.5%active weekly trend signals
MD69.2%positive activity pressure
RS53.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape53/100
Trend, activity pressure, participation, and risk combine to a 53/100 tape read.
Indicator analysis36/100Latest 12-week confirmation: trend 1/12, activity pressure 5/12, relative leadership 6/12.
Activity pressure 0.59; 2 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment59/100Weighted news tone is neutral across 18 relevant articles.
TD Cowen raises Amgen stock price target on strong earnings beat Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 69.89 BRL | 2.4% | 64.87 BRL | 56.81 BRL | 0.72 | 5.32 | 1.2K | Off |
| 24 Jul 2026 | 68.26 BRL | 2.3% | 64.14 BRL | 56.61 BRL | 0.77 | 4.98 | 448 | On |
| 17 Jul 2026 | 66.70 BRL | 0.8% | 64.03 BRL | 56.42 BRL | 0.69 | 2.48 | 3.6K | Off |
| 10 Jul 2026 | 66.18 BRL | -5.1% | 63.95 BRL | 56.24 BRL | 0.32 | -0.95 | 2.9K | Off |
| 3 Jul 2026 | 69.77 BRL | 5.4% | 63.77 BRL | 56.05 BRL | 0.02 | 6.32 | 2.8K | Off |
| 26 Jun 2026 | 66.22 BRL | 6.3% | 63.56 BRL | 55.83 BRL | -0.35 | 1.46 | 522 | Off |
| 19 Jun 2026 | 62.29 BRL | -2.8% | 63.53 BRL | 55.63 BRL | -0.71 | -1.93 | 0 | Off |
| 12 Jun 2026 | 64.11 BRL | -1.5% | 63.62 BRL | 55.47 BRL | -0.78 | -0.74 | 13 | Off |
| 5 Jun 2026 | 65.08 BRL | 7.4% | 63.58 BRL | 55.29 BRL | -0.95 | 1.80 | 1 | Off |
| 29 May 2026 | 60.60 BRL | -0.5% | 63.39 BRL | 55.11 BRL | -1.07 | -7.98 | 383 | Off |
| 22 May 2026 | 60.92 BRL | 3.1% | 63.26 BRL | 54.95 BRL | -1.01 | -9.10 | 3.3K | Off |
| 15 May 2026 | 59.08 BRL | 2.6% | 63.13 BRL | 54.79 BRL | -1.08 | -12.58 | 2.6K | Off |
| 8 May 2026 | 57.56 BRL | -5.7% | 63.06 BRL | 54.65 BRL | -1.07 | -18.14 | 6.6K | Off |
| 1 May 2026 | 61.06 BRL | -1.1% | 63.01 BRL | 54.52 BRL | -0.89 | -14.96 | 5.7K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.